ANEB
Anebulo Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.30
−10.23%Next report
Analyst consensus
- Next report date
- Sep 23, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- —
Latest reported
- Last report date
- Feb 12, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.13
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +32.6%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Feb 12, 2026 | -$0.13 | -$0.05 | Beat 61.54% | — |
| Nov 13, 2025 | -$0.12 | -$0.05 | Beat 58.33% | — |
| Sep 29, 2025 | -$0.07 | -$0.05 | Beat 23.08% | — |
| Feb 14, 2025 | -$0.08 | -$0.09 | Miss -12.50% | — |
| Nov 13, 2024 | -$0.05 | -$0.08 | Miss -60.00% | — |
| Sep 25, 2024 | -$0.13 | -$0.05 | Beat 61.54% | — |
| May 15, 2024 | -$0.11 | -$0.06 | Beat 45.45% | — |
| Feb 13, 2024 | -$0.11 | -$0.11 | In line | — |
| Nov 14, 2023 | -$0.11 | -$0.10 | Beat 9.09% | — |
| Sep 20, 2023 | -$0.10 | -$0.10 | In line | — |
| May 11, 2023 | -$0.16 | -$0.11 | Beat 31.25% | — |
| Feb 10, 2023 | -$0.11 | -$0.15 | Miss -36.36% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 23, 2026